Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Oxford Parkinson’s Disease Centre (OPDC) investigators, Professor Peter Magill, Professor of Neurobiology, Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, and Professor Laura Parkkinen, Professor of Translational Neuropathology, Nuffield Department of Clinical Neurosciences on their appointment to Group Leader roles in the new Parkinson’s Research Centre (PRC) - a £10m partnership between Parkinson’s UK and the UK Dementia Research Institute (UK DRI) dedicated to better understand the causes of Parkinson’s and to accelerate new and improved treatments for the condition.

The PRC was launched at a meeting held in London on Thursday 14th May where the appointed Group Leaders shared their vision for their future work. Professor Parkkinen will be looking to understand more about the pathological mechanisms that drive Parkinson’s while Professor Magill will be investigating the brain circuits affected in the condition. Both Laura and Peter will hold their UK DRI PRC Group Leader positions at the University of Oxford.

Professor Richard Wade-Martins, Head of the OPDC said, “I am absolutely delighted to see two outstanding Oxford scientists awarded Group Leader positions at the UK DRI PRC. Pete and Laura have played leading roles at the OPDC for fifteen years and now bring their expertise to this exciting new national initiative.”